小時糖耐量試驗的臨床意義(3)-預(yù)覽頁
【正文】 049 5059 6069 7079 8089 Prevalence (%) of newly diagnosed DM in DECODE populations The DECODE group, Diabetes Care 2022。354:617–621 1 . 0 00 . 5 80 . 5 20 . 5 60 . 5 90 . 8 20 . 4 70 . 5 00 . 5 40 . 6 60 . 8 40 . 9 20 . 00 . 20 . 40 . 60 . 81 . 01 . 25.255.256.246.257.797.8010.2510.2611.09=11.10Known DM=7.006.106.995.756.094.755.744.75Hazard Ratio (95% CI)2 h o u r g l u c o s e (m m o l / l ) F a s ti n g g l u c o s e (m m o l / l ) Allcause mortality has a linear relationship with 2hour plasma glucose DECODE, Diabetes Care 2022。 26:29102914 Hazard ratio (95% CI) by glucose status at baseline and at followup Followup Nondiabetic Diabetic Baseline 2hPG NGT IGT Nondiabetic CHD incidence 1 () () CVD mortality 1 () () Allcause mortality 1 () () Adjusted for age, sex, WHR, SBP, Chol, HDL and smoking Qiao et al. Diabetes Care 2022。152:27 Intensive Insulin Rx amp。 OR silent MI。 CVD: T1 DM DCCT/EDIC NEJM 2022。 CVD: IGT STOP NIDDM Analysis: Chiasson et al. JAMA 2022。 161:397404 Hazards ratio for mortality in diabetic patients according to FPG Mor ta li t y FP G ? 7. 0 mm ol/ l FP G ? 7. 0 mm ol/ l adj ust ed for 2 ho ur glu cos e CV D 1. 5 (1 .2 – 1. 9) 1. 2 (0 .9 – 1. 7) CH D 1. 4 (1 .0 – 2. 0) 1. 1 (0 .7 – 1. 7) Str oke 1. 9 (1 .2 – 3. 2) 1. 7 (0 .9 – 3. 1) All ca use 1. 7 (1 .4 – 1. 2) 1. 2 (1 .0 – 1. 4) The DECODE group, Arch Intern Med 2022。w z1C4G7JaMePhTkWnZr$u*x+A2E5H8KcNfQiUlXos%v) y0B3F6I9LdOgSjVmYq!tamp。v)z0C4F7IaMdPgSkVnZq$t*xA1D5G8KbNeQiTlWor%v( y+ B3E6H 9LcOgRjU mYp!samp。v) y0C3F7IaLdPgSjVnYq$t*wA1D4G8JbNeQhTl WoZr%u( y+B2E6H9KcOfRjU mXp!samp。wz1C4G7JbM ePhTkWnZr$u*x+A2E5H8KcNfQiUl Xps%v) y0B3F6IaLdOgSjVmYq!t*wz1D4G7JbMeQhTkWoZr$u( x+B2E5H9KcNfRi U mXpsamp。v)z0C3F7IaMdPgSkVnYq$t*xA1D5G8JbNeQhTl Wor%u( y+B2E6H9LcOfRjU mXp!samp。wz1D4G7JbMePhTkWoZr$u( x+ A2E5H 9KcNfRiUlXpsamp。w)z1C4F7JaMdPhSkVnZq$u*xA2D5G8KbNfQiTlXor %v( y0B3E6I9LcOgRjVmYp!tamp。v)z0C4F7IaMdPgSkVnYq$t*xA1D5G8JbN eQiTl Wor%u( y+B3E6H9LcOfRjU mYp!samp。w)z1C 4F7JaMePhSkWnZq$u*x+A2D5H8KbNfQi UlXos%v( y0B3F6I9LdOgRjVmYp!tamp。w)z0C 4F7IaMdPhSkVnZq$t*xA2D5G8KbNeQiTlXor%v( y+B3E6H9LcOgRjU mYp!samp。w)z1C4G7JaMePhSkWnZr$u*x+ A2D5H 8KcNfQiUlXos%v) y0B3F6I9LdOgSjVmYq!tamp。w)z0C4F7JaMdPhSkVnZq$u*x A2D5G8KbNfQiTlXor%v( y0B3E6I9LcOgRjVmYp!tamp。v) y0C 3F7IaLdPgSjVnYq$t*wA1D4G8JbMeQhTlWoZr%u( x+ B2E6H 9KcOfRiU mXp!samp。wz1C 4G7JaMePhTkWnZr $u*x+A2E5H8KcNfQi UlXps%v) y0B3F6IaLdOgSjVmYq!tamp。v) y0C 3F6IaLdPgSjVnYq!t*wA1D4G8JbM eQhTkWoZr%u( x+B2E5H9KcOfRi U mXpsamp。w)z1C 4G7JaMePhSkWnZr $u*x+A2D5H8KcNfQi UlXos%v) y0B3F6I9LdOgSjVmYq!tamp。v)z0C 3F7IaM dPgSkVnYq$t*xA1D 5G8JbNeQiTl Wor%u( y+B3E6H9LcOfRj U mYp!samp。wz1C 4G7JaMePhTkWnZr $u*x+ A2E5H8KcNfQiUlXps%v) y0B3F6IaLdOgSjVmYq!
教學(xué)課件相關(guān)推薦
鄂ICP備17016276號-1